COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,973 Articles (22,604 medRxiv, 8,369 bioRxiv)

Most recent first Previous |  Page 1737: Articles 17361-17370  | Next

Graphical Models of Pandemic
Chertkov, M., Abrams, R., Esmaieeli Sikaroudi, A. M., Krechetov, M., Slagle, C. N., Efrat, A., Fulek, R., Oren, E.
10.1101/2021.02.24.21252390 — Posted: 2021-03-01
Leveraging genetic data to elucidate the relationship between Covid-19 and ischemic stroke
Zuber, V., Cameron, A., Myserlis, E. P., Bottolo, L., Fernandez-Cadenas, I., Burgess, S., Anderson, C. D., Dawson, J., Gill, D.
10.1101/2021.02.25.21252441 — Posted: 2021-03-01
Synthetic protein antigens for COVID-19 diagnostics
Schein, C. H., McClellan, S. F., Levine, C. B., Negi, S. S., Braun, W., Dreskin, S., Anaya, E. S., Schmidt, J.
10.1101/2021.02.23.21251934 — Posted: 2021-03-01
Remdesivir as a tool to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
BERAUD, G., Timsit, J.-F., Leleu, H.
10.1101/2021.02.24.21252355 — Posted: 2021-03-01
A precise score for the regular monitoring of COVID-19 patients condition validated within the first two waves of the pandemic
Bakin, E. A., Stanevich, O. V., Belash, V. A., Belash, A. A., Sayenko, L. F., Korobenkov, E. A., Lioznov, D. A., Polushin, Y. S., Kulikov, A. N.
10.1101/2021.02.09.21249859 — Posted: 2021-03-01
Interpreting vaccine efficacy trial results for infection and transmission
Lipsitch, M., Kahn, R.
10.1101/2021.02.25.21252415 — Posted: 2021-02-28 Discussion: Onsite
Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake
Nguyen, L. H., Joshi, A. D., Drew, D. A., Merino, J., Ma, W., Kwon, S., Wang, K., Graham, M. S., Polidori, L., Menni, C., Sudre, C. H., Anyane-Yeboa, A., Astley, C. M., Warner, E. T., Hu, C., Selvachandran, S., Davies, R., Nash, D., Franks, P. W., Wolf, J., Ourselin, S., Steves, C. J., Spector, T. D., Chan, A. T., COPE Consortium
10.1101/2021.02.25.21252402 — Posted: 2021-02-28 Discussion: Onsite
Histopathological assessments reveal retinal vascular changes, inflammation, and gliosis in patients with lethal COVID-19
JIDIGAM, V. K., SINGH, R., BATOKI, J. C., MILLINER, C., SAWANT, O. B., BONILHA, V. L., RAO, S.
10.1101/2021.02.25.21251531 — Posted: 2021-02-28 Discussion: Offsite
GUIdeStaR (G-quadruplex, Uorf, IRES, Small RNA, Repeats), bioinformatics tool for gene characterization- case study: development of attribute selection and classification methods based on GuideStar for studying human transcription factor genes mediated by SARS-COV-2 small ncRNA
Kang, J. E.
10.1101/2021.02.25.432957 — Posted: 2021-02-27
A statewide analysis of SARS-CoV-2 transmission in New York
Lasek-Nesselquist, E., Singh, N., Russell, A., Lamson, D., Kelly, J., Plitnick, J., Pfeiffer, R. D., Tucker, N., Schneider, E., St. George, K.
10.1101/2021.02.20.21251598 — Posted: 2021-02-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).